|1.||Hassinger, Nancy L: 1 article (01/2005)|
|2.||Grill, Diane E: 1 article (01/2005)|
|3.||Chesebro, James H: 1 article (01/2005)|
|4.||Mruk, Jozef S: 1 article (01/2005)|
|5.||McBane, Robert D: 1 article (01/2005)|
|6.||Crain, E J: 1 article (10/2000)|
|7.||Meade, R P: 1 article (10/2000)|
|8.||Wexler, R R: 1 article (10/2000)|
|9.||Knabb, R M: 1 article (10/2000)|
|10.||Slee, A M: 1 article (10/2000)|
01/23/1992 - "In a rabbit arterial-venous shunt model mimicking arterial thrombosis, occlusion occurred within 30 min in 72% of control animals vs. 11% of animals treated with 0.1 mg kg-1 h-1 DuP 714. "
10/01/1992 - "Since thrombin plays an important role in platelet-mediated arterial thrombosis, we have examined the antiplatelet activity of a synthetic thrombin inhibitor, DuP 714 (Ac-(D)Phe-Pro-boroArg), in comparison with that of the naturally occurring inhibitor hirudin. "
01/01/2005 - "Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin."
10/01/2000 - "This study compared the antithrombotic effects of SK549 and a series of benzamidine isoxazoline fXa inhibitors with aspirin, DuP 714 (a direct thrombin inhibitor), recombinant tick anticoagulant peptide, or heparin in a rabbit model of electrically induced carotid arterial thrombosis. "
|6.||Aspirin (Acetylsalicylic Acid)
|7.||tick anticoagulant peptide
|1.||Angioplasty (Angioplasty, Transluminal)